Morris Cullen D, Gregoric Igor D, Cooley Denton A, Cohn William E, Loyalka Pranav, Frazier O H
Department of Cardiopulmonary Transplantation and Mechanical Circulatory Support, Texas Heart Institute, St. Luke's Episcopal Hospital, Houston, Texas 77225-0345, USA.
Heart Surg Forum. 2008;11(3):E143-4. doi: 10.1532/HSF98.20071180.
For patients with end-stage heart failure and contraindications to transplantation, insertion of a continuous-flow left ventricular assist device (LVAD) is an effective treatment strategy. We present a case of LVAD insertion in a 46-year-old man with cyanotic complex congenital heart disease and an extensive surgical history who presented with failure of his systemic ventricle. The insertion of an LVAD in our patient restored cardiac output and improved cyanosis and native ventricular function. As the number of patients with congenital heart defects surviving to adulthood increases, destination LVAD therapy may be increasingly considered as an alternative.
对于终末期心力衰竭且有移植禁忌症的患者,植入连续流左心室辅助装置(LVAD)是一种有效的治疗策略。我们报告一例46岁男性患者,患有紫绀型复杂性先天性心脏病且有广泛手术史,因体循环心室衰竭接受LVAD植入术。在我们的患者中植入LVAD恢复了心输出量,改善了紫绀和自身心室功能。随着存活至成年的先天性心脏缺陷患者数量增加,目标LVAD治疗可能会越来越多地被视为一种替代方案。